Liminal Biosciences Inc. (LMNL) Social Stream
Liminal BioSciences Inc (LMNL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LMNL.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $4.5 | $2.3 | $3.1 | $1.09 | 184.4% |
The Trend in the Analyst Price Target
LMNL's average price target has moved up $0.05 over the prior 53 days.
Over the past 41 weeks, LMNL's average upside potential has been 74.99%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 4 | 4.49836 | 2.29916 | 3.60037 | 2.52 | 42.87% |
| 2021-09-20 | 4 | 4.55875 | 2.33003 | 3.64870 | 2.52 | 44.79% |
| 2021-09-20 | 4 | 4.59382 | 2.34795 | 3.67677 | 2.52 | 45.9% |
| 2021-09-20 | 4 | 4.59672 | 2.34943 | 3.67909 | 2.52 | 46% |
| 2021-09-20 | 4 | 4.60909 | 2.35576 | 3.68899 | 2.52 | 46.39% |
| 2021-09-20 | 4 | 4.59270 | 2.34738 | 3.67588 | 2.52 | 45.87% |
| 2021-05-27 | 4 | 22.09544 | 2.81215 | 9.99288 | 4.23 | 136.24% |
| 2021-05-27 | 4 | 21.94338 | 2.79279 | 9.92411 | 4.23 | 134.61% |
| 2021-05-27 | 4 | 21.70496 | 2.76245 | 9.81628 | 4.23 | 132.06% |
| 2021-05-27 | 4 | 21.65459 | 2.75604 | 9.79350 | 4.23 | 131.52% |
| 2021-05-27 | 4 | 21.43579 | 2.72819 | 9.69455 | 4.23 | 129.19% |
| 2021-05-27 | 4 | 21.15995 | 2.69308 | 9.56980 | 4.23 | 126.24% |
| 2021-05-27 | 4 | 21.23538 | 2.70268 | 9.60391 | 4.23 | 127.04% |
| 2020-12-09 | 0 | 16.49348 | 4.63879 | 10.56538 | NA | NA% |
| 2020-12-09 | 2 | 16.49348 | 4.63879 | 10.56538 | NA | NA% |
| 2020-12-09 | 0 | 20.66880 | 5.81310 | 13.24000 | NA | NA% |
| 2020-12-09 | 2 | 20.66880 | 5.81310 | 13.24000 | NA | NA% |
| 2020-12-09 | 0 | 16.47350 | 4.63317 | 10.55258 | NA | NA% |
| 2020-12-09 | 2 | 16.47350 | 4.63317 | 10.55258 | NA | NA% |
LMNL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.5 | 0 | 0 | 3 | 1 | 1 | 4 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Liminal BioSciences Inc's average analyst price target is higher than 1.29% of all US stocks.
- In terms of how Liminal BioSciences Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than 16.24% of that group.
- Liminal BioSciences Inc's number of analysts covering the stock is higher than 25.49% of Pharmaceutical Products stocks.
- In the context of stocks in the small market cap category, Liminal BioSciences Inc's upside potential (average analyst target price relative to current price) is higher than 73.85% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Liminal BioSciences Inc are APRE, AVIR and ADAP.
Make investment decisions regarding LMNL using the data that counts. Try POWR Ratings for free.